Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 3,575.00
-390.00 (-9.84%)
At close: Jun 26, 2026
25.88% (1Y)
| Market Cap | 173.02B +99.1% |
| Revenue (ttm) | 24.02B -19.5% |
| Net Income | -5.71B |
| EPS | -177.15 |
| Shares Out | 45.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 671,441 |
| Open | 3,900.00 |
| Previous Close | 3,965.00 |
| Day's Range | 3,510.00 - 3,950.00 |
| 52-Week Range | 2,440.00 - 10,180.00 |
| Beta | 0.35 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |